Persevering through uncertainty
Like many venture-backed entrepreneurs and operators, I have been thinking about the relatively...
Naheed Kurji, Chief Executive Officer
Naheed Kurji is the Co-Founder, President and CEO of Cyclica. Naheed is passionate about building AI-augmented technologies that enable researchers to make more strategic and informed decisions in Healthcare and the life sciences. He spends the majority of his time obsessing over Cyclica’s culture, defining its strategy to best effect change in the pharma industry to achieve the company’s vision, and exploring opportunities for continued innovation.
The Trailblazers of Innovation
I've now made my way through 5 of Walter Isaacson's books, including The Innovators, Steve Jobs,...
Flipping the (Drug Discovery) Problem on its Head with Polypharmacology
For context: medicines have traditionally been designed to target a single protein with high...
Building a neo-biotech: It's all in the (dream) team. Meet them
I’m often asked how I can lead a deep tech biotech company that’s at the intersection of AI,...
Neither AI nor HI are the silver bullet, but combined, they are
Recently, the Reproducibility Project: Cancer Biology published work that suggests that “more than...
Cyclica successfully integrates DeepMind’s AlphaFold 2
AlphaFold 2 has provided structures for a large percentage of the proteome, perfectly complementary...
Full Speed Ahead: What DeepMind’s Newest Revelation means for Scientific/Research Advancement
Last Week, DeepMind announced on their blog that they had made available, in collaboration with...
Drug Repurposing for COVID19: What has been done, and how we're tackling it.
Originally published on LinkedIn: https://bit.ly/3EqDDeN
Over the past few weeks, we’ve strategized...
Raising Capital? My Dos and Don'ts Having Raised ~$40M.
Originally published on LinkedIn: https://bit.ly/3jLgf3L
At Cyclica, over the past 7+ years, we’ve...